Zongertinib, an oral therapy shown to have strong responses in patients previously treated for HER2 -mutated non–small cell ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced ...

On Saturday, May 3, more than 150 firefighters from five departments across the Atlanta area will join the American Lung Association to raise awareness and critical funds for people living with lung ...

Zongertinib shows promise for treating HER2-mutant non–small cell lung cancer (NSCLC), with significant activity against brain metastases and low interstitial lung disease risk, explains John Heymach, ...

A new Stanford blood test detects cancer and tissue damage by analyzing rare RNA fragments in the blood. Stanford Medicine ...

With the American Association for Cancer Research’s annual conference now underway, oncology researchers can expect ...

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 ...

Diliman has identified potential biomarkers or signs that can help with early lung cancer detection with the support of the ...

It's the third most-common cancer in the USA, and the leading cause of cancer deaths—and doesn't only affect whom you might ...

Young adults who smoke, drink heavily, and are inactive may be in danger of lasting health issues by the time they’re 36, ...

One of the original 12 defendants due at the Paris Assizes died last month, and another can no longer be judged because he is ...